The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 29203710)

Published in Philos Trans R Soc Lond B Biol Sci on January 19, 2018

Authors

Chengkai Dai1

Author Affiliations

1: Mouse Cancer Genetics Program, Center for Cancer Research NCI-Frederick, Building 560, Room 32-31b, 1050 Boyles Street, Frederick, MD 21702, USA chengkai.dai@nih.gov.

Articles citing this

Heat shock proteins as modulators and therapeutic targets of chronic disease: an integrated perspective. Philos Trans R Soc Lond B Biol Sci (2018) 0.75

Articles cited by this

(truncated to the top 100)

Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41

mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16

The heat-shock response. Annu Rev Biochem (1986) 20.16

AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell (2008) 16.72

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 15.71

Adapting proteostasis for disease intervention. Science (2008) 13.22

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature (2012) 10.39

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell (2007) 8.84

MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52

Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science (2003) 8.43

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer (2008) 7.93

Yeast heat shock factor is an essential DNA-binding protein that exhibits temperature-dependent phosphorylation. Cell (1988) 7.06

RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer (2011) 6.45

Targeting MET in cancer: rationale and progress. Nat Rev Cancer (2012) 6.43

AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res (2006) 6.22

HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med (2000) 6.20

Acetylation is indispensable for p53 activation. Cell (2008) 5.70

Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell (1998) 5.52

Colorectal cancer: mutations in a signalling pathway. Nature (2005) 5.42

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11

Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer (2006) 4.99

Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science (2009) 4.80

JNK signaling in apoptosis. Oncogene (2008) 4.72

Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63

Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell (2003) 4.63

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem (1998) 4.57

Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A (2000) 4.55

The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32

Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab (2011) 3.98

HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J (1999) 3.80

How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer (2008) 3.17

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res (2006) 3.12

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest (2011) 3.00

The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol (2014) 2.99

HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell (2012) 2.94

Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med (2004) 2.86

Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem (2011) 2.80

Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science (2013) 2.79

Drugging the undruggable RAS: Mission possible? Nat Rev Drug Discov (2014) 2.77

Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol (2014) 2.68

Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem (2005) 2.64

HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev (2007) 2.56

Getting in and out of mitosis with Polo-like kinase-1. Oncogene (2005) 2.44

Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci (2009) 2.21

RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol (2007) 2.20

Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol (2003) 2.17

Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol (2000) 2.11

The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell (2014) 2.06

High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03

Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell (2011) 1.99

Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J (1996) 1.98

The biology of proteostasis in aging and disease. Annu Rev Biochem (2015) 1.96

Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene (2007) 1.95

The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol (2012) 1.91

Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem (2006) 1.91

Protein kinase CK2 in mammary gland tumorigenesis. Oncogene (2001) 1.90

XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat Chem Biol (2011) 1.89

The role of HDAC6 in cancer. J Biomed Biotechnol (2010) 1.77

Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem (2005) 1.77

Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem (2005) 1.76

Targeted disruption of hsf1 leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsp molecular chaperones. J Cell Biochem (2002) 1.73

SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene (2012) 1.70

AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol (2014) 1.69

HSF4 is required for normal cell growth and differentiation during mouse lens development. EMBO J (2004) 1.69

Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res (2006) 1.64

GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget (2014) 1.56

Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res (2000) 1.54

Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol (2010) 1.47

Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab (2011) 1.47

Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene (2010) 1.45

Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem (2007) 1.38

The small heat-shock protein alpha B-crystallin promotes FBX4-dependent ubiquitination. J Biol Chem (2002) 1.35

Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ (2005) 1.28

The heat shock factor family and adaptation to proteotoxic stress. FEBS J (2010) 1.26

Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. J Clin Invest (2012) 1.25

mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PLoS One (2012) 1.25

Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet (2015) 1.19

KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter. J Biol Chem (2010) 1.18

Regulation of molecular chaperone gene transcription involves the serine phosphorylation, 14-3-3 epsilon binding, and cytoplasmic sequestration of heat shock factor 1. Mol Cell Biol (2003) 1.18

Quercetin suppresses heat shock response by down regulation of HSF1. Biochem Biophys Res Commun (1995) 1.13

Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer (2011) 1.12

JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol (2014) 1.11

Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis. J Cell Physiol (2012) 1.09

Protein kinase A as a biological target in cancer therapy. Expert Opin Ther Targets (2009) 1.09

Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis. J Biol Chem (2012) 1.05

Carney complex: an update. Eur J Endocrinol (2015) 1.04

Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia (2012) 1.04

c-Jun NH2-terminal kinase targeting and phosphorylation of heat shock factor-1 suppress its transcriptional activity. J Biol Chem (2000) 1.03

Transcriptional activity and DNA binding of heat shock factor-1 involve phosphorylation on threonine 142 by CK2. Biochem Biophys Res Commun (2003) 1.03

The LKB1-AMPK pathway-friend or foe in cancer? Cancer Cell (2013) 1.03

Protein kinase A binds and activates heat shock factor 1. PLoS One (2010) 1.02

MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1. Cell (2015) 1.02

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition. Oncotarget (2013) 1.02

The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma. Br J Haematol (2012) 1.00

A novel mouse HSF3 has the potential to activate nonclassical heat-shock genes during heat shock. Mol Biol Cell (2009) 0.99

RPA assists HSF1 access to nucleosomal DNA by recruiting histone chaperone FACT. Mol Cell (2012) 0.98

Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol Cell Biol (2012) 0.98

Polo-like kinase 1 phosphorylates heat shock transcription factor 1 and mediates its nuclear translocation during heat stress. J Biol Chem (2005) 0.98